Key Takeaways
- Consolidated loss, but operating businesses are turning: REL posted a consolidated H1 loss of ₹145 crores, yet the core operating entities (Care, RFL, RBL) all showed improving profitability or revenue momentum, suggesting the drag is concentrated at the holdco and housing finance levels.
- Care Health is running ahead of its own profitability curve: H1 PBT rose 42% YoY to ₹392 crores, and management now says it is "well ahead" of its March '28 combined ratio target of near 100%, with the ratio already at 100.5%.
- RFL's decade-long restart is now real: After 10 years, Religare Finvest disbursed its first loan and opened three branches, with a stated ambition to build a ₹10,000–15,000 crores secured retail book over four to five years.
- The demerger remains a high-priority, no-timeline catalyst: Management reiterated the demerger is a priority and discussions with regulators are ongoing, but explicitly declined to provide any timeline, making it a binary unlock with an unknowable date.
- What to watch next quarter: The pace of RFL's branch and book build-out, any exposure draft on distribution regulations that could reset Care's cost structure, and whether the ₹880 crores in remaining warrant inflows arrive ahead of the March 2027 deadline.
Care Health Insurance: The Earnings Engine
- Profitability surged on better underwriting: H1 FY27 PBT grew 42% YoY to ₹392 crores, driven by a 90 bps improvement in the retail loss ratio to 66.1% and a 70 bps improvement in the combined operating ratio to 100.5%, even as the expense ratio stayed flat at 34.4% despite 35% GWP growth.
- New business is masking operating leverage: The expense ratio held nearly flat because new business growth (over 50%) far outpaced renewal growth, so the acquisition cost of new policies absorbed the efficiency gains visible in the renewal book.
- Retail persistency jumped: The retail health persistency rate improved to 97% from 91%, a signal of better policyholder retention that supports future premium stability.
- GAAP vs. Ind AS optics: The GAAP claims ratio rose from ~70% to ~73% QoQ, but management insists only the Ind AS (1/365) ratio is meaningful, where the retail loss ratio actually declined 90 bps.
- Capital raised proactively: Care raised ₹300 crores in Tier 2 capital during the quarter and another ₹150 crores in October 2026, with a ₹300 crores rights issue planned for November, all described as debt-equity optimization rather than a substitute for holdco support.
Ajay Shah: "On the combined, around last, last investor con-call, I had insisted and I had made a future guidance-looking statement that we'll be near 100% in March '28. We seem to be well ahead of that curve."
Religare Finvest: The Restart
- Lending resumed after a decade: RFL disbursed its first loan just before Diwali and opened branches in Lucknow, Kanpur, and Noida in the first week of November 2026, with the next phase planned for Tamil Nadu, Rajasthan, and Maharashtra.
- Profitability is already strong, but from recoveries: Q2 total income rose to ₹44.8 crores from ₹20 crores and PAT to ₹49 crores from ₹30.8 crores, driven by healthy recoveries from the GNPA book, which also pushed NII to ₹39.3 crores from ₹18.5 crores. Net NPA is nil and collection efficiency remains ~100%.
- The new lending playbook is secured-first: The approach is tech-led underwriting with branch-led relationships, focused on secured retail products with faster decisions and fewer touchpoints, and an explicit "growth with guardrails" philosophy.
- Ambition is a multi-line NBFC at scale: Management targets a ₹10,000 to ₹15,000 crores book over four to five years, with an overall ROA aspiration of 2.5% to 2.8% and a target portfolio yield of ~15.5%, built out over the next 12 to 16 quarters.
Pratul Gupta: "The capital is in place, the branches are open, and the first loan has been disbursed. The priority now is to grow carefully with quality and collection setting the pace."
Broking & Housing: Build-Out Mode
- Broking revenue grew despite a subdued market: RBL total income rose 9% YoY to ₹97.4 crores in Q2, with growth in the client funding book and distribution income offsetting regulatory changes that weighed on trading volumes and brokerage revenue.
- H1 profitability improved on operating leverage: H1 PBT grew 29% to ₹13 crores, with brokerage income up 13% and interest income up over 21% driven by a client debit book that expanded over 50%, though Q2 PAT was broadly flat at ₹2.5 crores.
- Capital and ratings support the build-out: REL infused ₹100 crores into RBL via a rights issue in August 2026, and CRISIL upgraded the long-term rating to BBB+ Stable from BBB Stable, while CARE Ratings reaffirmed at BBB+ and A2.
- Housing finance is still pre-revenue: RHDFCL's Q2 loss widened to ~₹8 crores from ~₹5 crores in Q1 as operating expenses reached close to ₹17 crores for H1, mainly from higher depreciation and technology costs tied to an ongoing IT transformation, though the 1+ delinquency pool improved to 19% on stepped-up collections.
- REL committed ₹250 crores to RHDFCL and hired a new leadership team under Mr. Pavan Gupta, with the business expected to start lending in January.
Holding Company & Structure
- Standalone holdco remains a loss center: REL standalone reported a Q2 loss of ~₹13 crores because income was only a little over ₹3 crores against expenses of ~₹16 crores, reflecting its nature as a pure holding entity with no operating income.
- RBI cleared promoter directors: The RBI approved the appointment of Dr. Anand Burman, Mr. Aditya Burman, Mr. Mohit Burman, and Jimeet Modi as directors on the REL board, removing a key regulatory overhang.
- Warrant inflows provide a visible capital path: The remaining ₹880 crores from warrants is expected to flow in by March 2027, with some money possibly arriving earlier, giving the holdco a defined runway to support subsidiaries.
- Demerger is high-priority but unanchored: Management confirmed it remains in touch with regulators and advisors and will update the board first, but explicitly stated no timeline can be given, leaving the catalyst entirely dependent on regulatory process.
Arjun Lamba: "Now all the building blocks are in place, be it management teams, capital, tech platforms, board, and governance. So I think the ingredients are there and we would hopefully be bringing good news to you on these platforms in the coming quarters."
Regulatory & Accounting Crosswinds
- Distribution regulation is the known unknown: Management is awaiting the IRDAI exposure draft on distribution regulations and declined to provide premium growth guidance or quantify impact, stating it will comment probably in the March timeframe, though it expects to maintain a 99% to 100% combined ratio even with short-term pain.
- Ind AS adoption creates a solvency tailwind: Care filed for forbearance for only one year, so next year's results will be on an Ind AS basis, and if solvency calculation also shifts to Ind AS, the ₹1,000+ crores net worth difference will add to the base, showing a materially higher solvency number.
- I-GAAP profitability normalizes from next year: As Care begins unwinding three-year business from next year onward, normalized profits even on an I-GAAP basis are expected, meaning additional capital might not be required even without a regulatory change in solvency methodology.
- Holding company merger guidelines not directly applicable: Management noted the IRDAI paper on holding companies merging with operating entities does not apply apple-to-apple to Religare given its multiple entities under REL, but the company is aware of the guidelines.
Ambrish Jindal: "So the moment the solvency is shifted on an Ind AS basis, this INR1,000 crores is going to add to that base and we are going to see a very different number for the solvency."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Care combined ratio | Maintain 99% to 100% combined ratio, even with distribution regulation changes | Ongoing, with possible short-term pain |
| Care Ind AS profitability | 1/n basis numbers turn "very positive" | From October 2027 (Q3 FY27) |
| Care I-GAAP profit normalization | Normalized profits even on I-GAAP basis as three-year business unwinds | From next financial year (FY27) or next-to-next |
| Care capital self-sufficiency | Business self-sustaining without requiring capital infusion | Maybe from next year onwards |
| RFL book size | Build a ₹10,000 to ₹15,000 crores retail loan book | Four to five years |
| RFL ROA | Overall ROA of 2.5% to 2.8%; secured products at 2% to 2.5% | Short term |
| RFL portfolio yield | Target yield on book at ~15.5% | Not specified |
| Non-Care businesses potential | Full potential visible across broking, NBFC, and housing finance | ~24 months |
| Warrant inflows | Remaining ₹880 crores to flow into REL | By March 2027, with some possibly earlier |
| Housing finance launch | RHDFCL to begin lending operations | January 2027 |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Consolidated total income | ₹2,390 cr |
| Consolidated loss before tax | ₹128 cr |
| Consolidated net worth | ~₹3,000 cr as of September 30, 2026 |
| H1 FY27 consolidated total income | ₹4,717 cr, +19% YoY |
| H1 FY27 consolidated loss after tax | ₹145 cr |
| Care Health Insurance H1 PBT (Ind AS) | ₹392 cr, +42% YoY from ₹276 cr |
| Care Health Insurance H1 GWP growth (full premium) | 35% YoY; retail business grew 44% YoY |
| Care Health Insurance H1 loss ratio (Ind AS) | 66.1%, improved 90 bps YoY |
| Care Health Insurance H1 combined operating ratio (Ind AS) | 100.5%, improved 70 bps YoY |
| Care Health Insurance H1 ROE based on PBT (non-annualized) | 12.1% vs 10.2% in H1 FY26 |
| Care Health Insurance solvency ratio (I-GAAP) | 1.55x |
| Care Health Insurance retail health persistency rate | 97%, improved from 91% |
| Care Health Insurance retail health market share | 12.8% among industry, 21.3% among SAHIs |
| Care Health Insurance investment AUM | ₹12,900 cr |
| Religare Broking Q2 total income | ₹97.4 cr, +9% YoY |
| Religare Broking Q2 PAT | ₹2.5 cr vs ₹2.6 cr in Q2 FY26 |
| Religare Broking H1 PBT | ₹13 cr, +29% YoY |
| Religare Broking assets under custody | Over ₹56,000 cr |
| Religare Broking cash segment ADTO | ₹320 cr, up from ₹274 cr YoY |
| Religare Finvest Q2 total income | ₹44.8 cr vs ₹20 cr in Q2 FY26 |
| Religare Finvest Q2 PAT | ₹49 cr vs ₹30.8 cr in Q2 FY26 |
| Religare Finvest Q2 net interest income | ₹39.3 cr vs ₹18.5 cr in Q2 FY26 |
| Religare Finvest net NPA | Nil |
| Religare Finvest CRAR | Over 230% |
| Religare Finvest tangible net worth | ₹963 cr |
| Religare Housing Finance AUM | Above ₹240 cr, 67% home loans, 33% LAP |
| Religare Housing Finance Q2 loss | ~₹8 cr vs ~₹5 cr in Q1 FY27 |
| Religare Housing Finance 1+ delinquency pool | 19%, reduced during the quarter |
| Warrants funds received | ₹619 cr of ₹1,500 cr; ₹880 cr remaining, maturity March 2027 |